Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 03:00 ET | Source: Avance Clinical

Avance Clinical Showcases Early Phase Expertise and the Australian Advantage for EU Biotechs at BIO-Europe Vienna

Avance Clinical Showcases Early Phase Expertise and the Australian Advantage for EU Biotechs at BIO-Europe Vienna
October 30, 2025 16:15 ET | Source: Certara

Certara Expands Biosimulation Market with AI-Driven QSP Platform

Certara today announced the launch of Certara IQ, a scalable, AI-powered Quantitative Systems Pharmacology (QSP) solution.
October 30, 2025 09:00 ET | Source: Avance Clinical

Avance Clinical Launches Renal and Cardiometabolic Center of Excellence to Optimize Patient Recruitment to Elevate Study Success

The center strategically places scientific experts across key regions to maximize patient access and sponsor success.
October 30, 2025 07:30 ET | Source: Epicured

Epicured Appoints Industry Veteran Patricia Bradley to Oversee Life Sciences Business

Epicured has appointed industry veteran Patricia Bradley as its Senior Vice President, Life Sciences and Clinical Development Partnerships.
October 28, 2025 09:00 ET | Source: Avance Clinical

Avance Clinical Unveils Dedicated CNS Center of Excellence for Expert Clinical Trial Services in Neuroscience

Avance Clinical today announced the launch of its Center of Excellence dedicated to central nervous system (CNS) disorders.
October 20, 2025 09:00 ET | Source: Avance Clinical

Avance Clinical Launches Dedicated Center of Excellence to Accelerate Early Phase Biotech Trials

Avance Clinical Launches Dedicated Center of Excellence to Accelerate Early Phase Biotech Trials
October 20, 2025 08:00 ET | Source: Certara

Certara Scientists are Among the Topmost Cited Biopharma Researchers

Certara celebrates its 200 published papers and 11 scientists on the Stanford/Elsevier top 2% cited researchers list in 2025.
October 18, 2025 06:05 ET | Source: Precede Biosciences, Inc.

Precede Biosciences Presents New ESMO 2025 Data Demonstrating Its Liquid Biopsy Platform’s Ability to Resolve Target Expression and Molecular Subtypes in Small Cell Lung Cancer

Precede Biosciences Presents New Data Demonstrating Its Liquid Biopsy Platform’s Ability to Resolve Target Expression and Molecular Subtypes in SCLC
October 15, 2025 10:03 ET | Source: Spanios

Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase 1 Study in Patients with Sarcoma

HOUSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) is collaborating with Spanios on a non-clinical study using New Alternate Methodologies (NAM)-based...
October 08, 2025 04:55 ET | Source: SAI LIFE SCIENCES LIMITED

Sai Life Sciences, Agility Life Sciences, and Centrix Pharma Solutions announce an ‘Integrated CMC Partnership’ to accelerate drug development for innovators

MANCHESTER, United Kingdom and HYDERABAD, India, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), Agility Life Sciences, and Centrix Pharma Solutions today announced...